A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder.
Mi W, Di X, Wang Y, Li H, Xu X, Li L, Wang H, Wang G, Zhang K, Tian F, Luo J, Yang C, Zhou Y, Xie S, Zhong H, Wu B, Yang D, Chen Z, Li Y, Chen J, Lv S, Yi Q, Jiang Z, Tian J, Zhang H.
Mi W, et al. Among authors: wu b.
Transl Psychiatry. 2023 May 10;13(1):163. doi: 10.1038/s41398-023-02435-0.
Transl Psychiatry. 2023.
PMID: 37164957
Free PMC article.
Clinical Trial.